Astrid Pentz-Murr

My 'Twitter me' cares about #AMR, knowledge sharing, maternal health & more.
Views expressed are my own.

[Astrid Pentz-Murr @AstridPentz]

365 days since I nearly died from an infection and #postpartumhemorrhage. I am here because I had access to the most excellent care, 15+ HCPs working tirelessly for hours, 13 units of blood, state of the art treatments and #antibiotics that work.

What a privilege to be alive.

[Steve Sweeney @SweeneySteve]

Western media outlets have flocked back to Lebanon since March 2, using buzzwords and phrases like “Hezb0llah stronghold” and “Iranian-backed militia” which serve a purpose: to signal that these areas, towns and cities deserve to be bombed.

Here ITV News uses this phrase to describe Tyre, one of the oldest cities in the world , ignoring its rich history and significant role as a maritime power and reducing it to an area where Hezb0llah “rules the roost”.

It’s not simply shoddy journalism. The messaging and framing is deliberate and a reminder that the Western media acts as the propaganda arm of the very states that are arming I$rael to the teeth while it carries out a genocide in Gaza and an ethnic cleansing operation on a scale larger than the Nakba in Lebanon.

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

Our REVIVE team will also be at #ESCMIDGlobal.

REVIVE supports the antimicrobial R&D community by connecting researchers with experienced antibiotic developers and creating spaces for learning and knowledge exchange.

If you’re working in this space, come meet the team at our Booth G71!

[Robert Inlakesh @falasteen47]

BREAKING: Israel Carries Out A Beach Massacre In Beirut

An Israeli strike reportedly targeted displaced people’s tents in the Ramla al-Bayda beach area. A huge number of dead & injured.

An outrageous war crime reminiscent of the massacres carried out in Gaza.

[Astrid Pentz-Murr @AstridPentz]

@R_H_Ebright @gardp_amr @CFAMRSyndicate It works for me. If it still doesn't work on your end, please try via the REVIVE website: https://t.co/olsHpYv9HT

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

Serious bacterial infections cause 7.7M deaths every year.
Drug resistance is outpacing innovation, leaving few safe treatments.

François Franceschi explains how GARDP is acting now to change this.

#WAAW2025 #AMR #Antibiotics

@fjfranceschi I @anand_bugworks I @ShionogiUS

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

📢 Exciting news!

Selected articles from our Antimicrobial Viewpoints series will now be co-published in CMI Communications, @ESCMID's open-access journal.

This collaboration will expand the reach and amplify the impact of these articles within the antimicrobial R&D community.

Do you have an idea for a topic of interest for the antimicrobial R&D community? Why not suggest it to the REVIVE team at [email protected]?

@CMIComms

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

⏳ One month left to submit your abstract for #ACC2026!

If your research can advance how we tackle #AMR - from child and maternal health to AI in healthcare — this is your chance to share it with a global audience.

📅 Deadline: 14 Nov 2025, 17:00 GMT
🔗 https://t.co/0q30Ve8FrB

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

We recently had the pleasure to discuss the progress of the #REVIVE programme and potential new activities in our second annual advisory meeting.

A big Thank You to our 2026 REVIVE programme Advisory Group members:
Mark Blaskovich, Olga Genilloud, Laura Hollis, Samuel Kraus, Jimmy Nkaiwuatei, Christina Obiero, Marnie Peterson and Will Stubbings (who unfortunately couldn’t attend).

Your input is highly appreciated, and we are looking forward to developing new exciting and enlightening content soon – watch this space!
🔗https://t.co/s9tK0fJWpr

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

📝 Call for abstracts is open for #ACC2026!

We’re inviting researchers to share their work on #AMR for short talks or as poster presentation to spark cross-disciplinary discussion.

💡 Themes include (but are not limited to):
- Child & maternal health
- Stewardship & access
- Diagnostics & innovation
- Clinical research & new treatments
- AI in healthcare & AMR

⏳ Deadline: 14 Nov 2025, 17:00 GMT

🔗 https://t.co/MIjLbk1Sll

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

🚀 Exciting news!

Registration is now open for #ACC2026- a *FREE* virtual conference co-organized by GARDP & @BSACandJAC, joined this year by @ADVANCE__ID & @MahidolU.

🌍 Join us as we dive into the latest advances in antimicrobial discovery, development and access.

📅 4 & 5 February 2026

Don’t miss out!
🔗 https://t.co/6X4w0TTSQU

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

📢 Happening today

Make sure to join our #REVIVE webinar on Overcoming Challenges of Tuberculosis Drug Discovery and Development with Jeremy Rock, Dirk Schnappinger and Laura Cleghorn. The webinar will be moderated by @ValerieMizrahi.

⏰15:30-17:00 CEST
🔗 https://t.co/5DlGfdLFdU

#Tuberculosis #TB #AMR #REVIVE #GARDP

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

Join @INCATEurope's next Entrepreneurs session on using a Target Product Profile (TPP) when developing AMR solutions 💡

🔗Register now: https://t.co/bvlBdF0M6g

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

Syphilis is resurging with congenital cases rising too.

At our upcoming REVIVE webinar, infectious disease experts will share what’s working, what’s not and why new treatments are urgently needed.

📅 19 August 2025, 17:00-18:30 CEST
📍 Online
Register here: https://t.co/hbZx9GEXmw

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

Tuberculosis still kills over a million people a year, but drug development is lagging. Join our next REVIVE webinar with researchers from the US, UK and South Africa as they break down new targets, tools and ideas shaping the future of TB treatment.

📅 9 September 2025, 03:30-05:00 PM CEST
📍 Online
🔗 Register now: https://t.co/5DlGfdLFdU

#Tuberculosis #REVIVE

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

📅 Save the Date: ACC2026

The Antimicrobial Chemotherapy Conference (ACC2026) is coming your way in February 2026!

This year, GARDP and @BSACandJAC are teaming up with @ADVANCE__ID and @MahidolU to develop this one-of-a-kind online conference.

🗓️ Programme details and registration coming in September

In the meantime, take a look back at past conferences:

🔗 https://t.co/PWZWxnxHqR

[António Guterres @antonioguterres]

Let’s be clear: The creeping annexation of the occupied West Bank is illegal.
It must stop.

The wholesale destruction of Gaza is intolerable.
It must stop.

Unilateral actions that would forever undermine the two-state solution are unacceptable.
They must stop.

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

🎥 Not sure where to start with AntibioticDB website?

Our short video guide walks you through how to search, filter, and explore 3,000+ antibacterial agents.

Fast, clear, and built for researchers, developers, and decision-makers.

🔴▶️ See how it works:
https://t.co/4iKG3oA5S2

@GuidetoPHARM

#AMR #OpenAccess #REVIVE

[The Resonance @Partisan_12]

“Israel & the United States are the biggest threats to humanity & you are feeding the monster. Israel attacks iran illegally while it continues the genocide of Palestinans....”

—Spanish MEP Irene Montero Criticizes EU Leaders Over Support for Israel's Attack on Iran.

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

Part 2 of GARDP’s clinical trial to evaluate effective antibiotic combinations for newborns with sepsis has started at Tygerberg Hospital in Cape Town!

This could be lifesaving for babies. The trial aims to recruit 3,000 babies across 2 continents by 2028. 🌍

https://t.co/9YptJFYO8H

@CityStG_Health
@AMR_CNPI
@SUhealthsci
@AngelaD_ZA

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

💻📱 AntibioticDB Relaunched: New Functions, More Compounds, and Richer Data to Accelerate Antibiotic Discovery

A global, open-access resource for researchers, developers and innovators working to address antimicrobial resistance.

Led by GARDP since 2022, AntibioticDB brings together data on 3,000+ antibacterial agents—from licensed antibiotics and clinical candidates to experimental compounds and non-traditional therapies like anti-virulence agents, bacteriophages, and host-directed treatments.

Start exploring ⬇️
🔗 https://t.co/GhsUTfuJMZ

#OpenAccess #REVIVE